CytomX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.About CTMX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.
CEOSean A. McCarthy
CEOSean A. McCarthy
Employees122
Employees122
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2010
Founded2010
Employees122
Employees122
CTMX Key Statistics
Market cap347.42M
Market cap347.42M
Price-Earnings ratio-95.88
Price-Earnings ratio-95.88
Dividend yield—
Dividend yield—
Average volume350.58K
Average volume350.58K
High today$5.85
High today$5.85
Low today$1.67
Low today$1.67
Open price$3.25
Open price$3.25
Volume206.37M
Volume206.37M
52 Week high$5.85
52 Week high$5.85
52 Week low$1.04
52 Week low$1.04
CTMX News
Benzinga 7h
Crude Oil Down 3%; ISM Manufacturing PMI Falls In April - CytomX Therapeutics, Cemtrex ... - BenzingaLoading... Loading... U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Wednesday. The Dow traded up 0.33% to 3...
Benzinga 7h
What's Going On With CytomX Stock?Loading... Loading... CytomX Therapeutics, Inc. CTMX shares are racing higher Wednesday. The company said it will report first-quarter results and provide an i...
Simply Wall St 4d
CytomX Therapeutics, Inc. Not Doing Enough For Some Investors As Its Shares Slump 27% - Simply Wall StCytomX Therapeutics, Inc. ( ) shareholders won't be pleased to see that the share price has had a very rough month, dropping 27% and undoing the prior period's...
Analyst ratings
86%
of 7 ratingsBuy
14.3%
Hold
85.7%
Sell
0%
More CTMX News
Seeking Alpha 6d
CytomX Therapeutics: More Than One Masked Immunotherapy Company - Seeking Alphaaerogondo/iStock via Getty Images Topline Summary CytomX Therapeutics (NASDAQ:CTMX) is a biotech company specializing in the development of anticancer therape...
